Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Interpace Biosciences Q2 Revenue USD 9.131 Million

BRIEF-Interpace Biosciences Q2 Revenue USD 9.131 Million

ReutersReuters2026/08/10 20:36

Aug 10 (Reuters) - Interpace Biosciences Q2 operating income USD 321 thousand.

  • Q2 net income USD 158 thousand
  • Q2 operating expenses USD 5.332 million
  • Q2 gross profit USD 5.653 million
  • Q2 net income continuing operations USD 266 thousand
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!